Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Anticoagulants: Classification, Mechanism of Action, and Therapeutic Uses, Slides of Pharmacology

This presentation provides a comprehensive overview of anticoagulants, covering their classification, mechanisms of action, and therapeutic uses. It delves into the different types of anticoagulants, including parenteral and oral agents, and explores their pathways and adverse effects. The presentation also highlights the mechanism of action of key drugs like heparin and warfarin, providing valuable insights into their clinical applications.

Typology: Slides

2024/2025

Uploaded on 03/30/2025

mizanur-khan
mizanur-khan 🇮🇳

4 documents

1 / 14

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
PRESENTATION ON ANTI COAGULATNS
pf3
pf4
pf5
pf8
pf9
pfa
pfd
pfe

Partial preview of the text

Download Anticoagulants: Classification, Mechanism of Action, and Therapeutic Uses and more Slides Pharmacology in PDF only on Docsity!

PRESENTATION ON ANTI COAGULATNS

CONTENTS

Introduction

Classification of Anticoagulants

Pathways

Mechanism of action

Therapeutics Uses

Adverse Effects

Classification of Anti Coagulants 1) USED IN VIVO: A) PARENTERAL ANTICOAGULANTS: (a)INDIRECT THROMBIN INHIBITORS : Heparin Low molecular weight heparins Fondaparinux Danaparoid (b) DIRECT THROMBIN : Lepirudin Bivalirudin Argatroban

B) ORAL ANTICOAGULANTS:
COUMARIN DERIVATIVES:

Bishydroxcoumarin (dicumarol) Warfarin sodium Acenocoumarol DIRECT FACTOR Xa INHIBITORS: Ethylbiscoumacetate Rivaroxaban ORAL DIRECT THROMBIN INHIBITOR: Dabigatran, etexilate

Pathways:

Mechanism of important drugs used in anti coagulatns:  (^) ANTICOAGULANT ACTION OF HEPARIN: HEPARIN Activates plasma AT Il Heparin-AT Ill complex Binds to clotting factors of intrinsic and common pathways (Xa, la, IXa, Xla, Xlla and Xllla) and inactivates them

WARFARIN MOA:

Warfarin and its congeners act as anticoagulants only in vivo, not in vitro. This is so because they act indirectly by interfering with the synthesis of vit K dependent clotting factors in liver. They apparently behave as competitive antagonists of vit K and lower the plasma levels of functional clotting factors in a dose-dependent manner. In fact, they inhibit the enzyme vit K epoxide reductase (VKOR) and interfere with regeneration of the active hydroquinone form of vit K (Fig. 45.2) which acts as a cofactor for the enzyme γ-glutamyl carboxylase.

Fig:moa of oral anticoagulant

REFERENCE: “ESSENTIAL OF MEDICAL PHARMACOLOGY” TH Edition By KD Tripathi,Page no:

THANK YOU